Name
Bryostatin
Alternate Names
B705008K112
Bryostatin-1
Abbreviations
None
Category
Chemotherapy
Subcategory
Protein kinase activator
NSC Number
339555
Primary Site
Breast
cervical
esophageal
gastric
head & neck
kidney
leukemia
metastatic solid tumors
ovarian
prostate cancer
Histology
None
Remarks
Used to treat a variety of malignancies including sarcomas, lymphomas, leukemias, breast, colon and lung cancers. No information on FDA approval to treat these neoplasms as of April 2024.
Coding
This drug should be coded